Meridian Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $564K | Hold |
3,498
| – | – | 0.02% | 417 |
|
2025
Q1 | $595K | Hold |
3,498
| – | – | 0.03% | 379 |
|
2024
Q4 | $581K | Hold |
3,498
| – | – | 0.03% | 380 |
|
2024
Q3 | $601K | Buy |
+3,498
| New | +$601K | 0.03% | 378 |
|
2024
Q1 | – | Sell |
-3,498
| Closed | -$553K | – | 300 |
|
2023
Q4 | $553K | Sell |
3,498
-552
| -14% | -$87.2K | 0.04% | 364 |
|
2023
Q3 | $593K | Hold |
4,050
| – | – | 0.04% | 330 |
|
2023
Q2 | $620K | Hold |
4,050
| – | – | 0.05% | 286 |
|
2023
Q1 | $628K | Hold |
4,050
| – | – | 0.05% | 286 |
|
2022
Q4 | $624K | Hold |
4,050
| – | – | 0.06% | 267 |
|
2022
Q3 | $535K | Sell |
4,050
-282
| -7% | -$37.3K | 0.06% | 264 |
|
2022
Q2 | $587K | Hold |
4,332
| – | – | 0.05% | 321 |
|
2022
Q1 | $646K | Sell |
4,332
-200
| -4% | -$29.8K | 0.07% | 201 |
|
2021
Q4 | $734K | Hold |
4,532
| – | – | 0.08% | 196 |
|
2021
Q3 | $752K | Buy |
4,532
+138
| +3% | +$22.9K | 0.09% | 178 |
|
2021
Q2 | $758K | Buy |
4,394
+62
| +1% | +$10.7K | 0.1% | 175 |
|
2021
Q1 | $695K | Hold |
4,332
| – | – | 0.1% | 173 |
|
2020
Q4 | $727K | Buy |
+4,332
| New | +$727K | 0.12% | 147 |
|
2019
Q3 | – | Sell |
-260
| Closed | -$367 | – | 281 |
|
2019
Q2 | $367 | Buy |
+260
| New | +$367 | 0.01% | 421 |
|